Unilever PLC (UL)
Consumo básico / Cuidado personal y del hogar
Unilever trades at 21× on recurring earnings that the market still reads through a reported turnover that is falling, when underlying volume is growing at its best pace in more than a decade and the company raised its full-year guidance; at market price the estimated total return is +8% annually and the verdict is Fairly valued.
- Price
- $65.21
- Intrinsic value (5y, base)
- $82
- Total annual return (5y)
- 8.1%
- Status (nominal)
- Fairly valued
- Margin of safety
- +15%
The essentials
- Portfolio of personal and home care brands present in 190 countries; priority brands account for 78% of 2025 turnover.
- The first half of 2026 delivered 4.8% underlying growth with 4.2% volume, and the company raised its full-year guidance to a range of 4% to 6%.
- Return on invested capital is 15%, comfortably above the 10% bar, on a capital base that carries decades of acquisitions.
- The combination of the food business with McCormick, announced in March 2026, removes roughly a quarter of turnover and funds €6,000 million of buybacks through 2029.
Intrinsic value — two valuation methods
Total return at 5 years: 4.6%/year = 1.6% appreciation + 3.0% dividend. The target price ($71) is ex-dividend; the $10 in dividends collected over 5 years are added separately.
By both methods, the value today (DCF $80 · Multiples $66) exceeds the market price ($65).
Pillars of the analysis
The verdict — today vs 5 years
Today — fairly valued: at $65 trades close to its value discounted to today (~$66); the discount is positive but does not reach the margin of safety we require (≥38%).
At 5 years — En valor: the target price ($71) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.
The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$42.
Thesis
The business
A branded mass consumer goods business, with return on invested capital of 15.4% against the 10% bar, that generates cash predictably and returns practically everything it earns. The moat is brand and scale based, wide and stable. What changed over the past year is the growth mix: volume has taken the lead over price, which is the healthy way for a consumer goods manufacturer to grow, and the company raised its full-year guidance in July 2026.
The valuation
It is valued by multiples, with a single exit multiple applied to normalized attributable net income, which is the method that fits a mass consumer goods manufacturer with immaterial stock-based compensation and maintenance capex close to depreciation. Year zero is the fiscal year ended December 31, 2025, normalized to exclude the accounting gain on the ice cream spin-off. The entire framework is in euros and is converted to dollars only once, at the close of the cascade. Over five years the estimated value per share is $71, which against today's $65 implies a total return of +5% annually.
The margin of safety
It trades close to intrinsic value, far from the required margin of safety. Today's entry multiple is 21×, within the range at which quality mass consumer goods manufacturers trade, and the dividend yield contributes +3% of the estimated return. The discipline is not in the exit multiple, which is derived from the staple archetype's band and from the position that corresponds to it by terminal growth, moat and return on capital, but in the minimum required return: against the method's three thresholds, this is a case of quiet compounding, not deep discount.
What to watch
The test that decides the thesis is whether the volume-led growth of the first half of 2026 holds without giving back price. Home Care already grows almost without price (0.2 points in the half) and is the lowest-margin category: if that dynamic spreads to Personal Care and Beauty, underlying operating margin stops improving and the base-case earnings path does not hold. The second test is execution of the McCormick combination: the separation consumes charges and management attention, and the €6,000 million buyback through 2029 partly depends on its proceeds.
Educational / informational. Does not constitute investment advice.